Baum, Hedlund, Aristei & Goldman represents families whose children were born with Persistent Pulmonary Hypertension of the Newborn (PPHN) after their mothers' ingestion of the antidepressant drug Celexa®, during pregnancy.
As a pharmaceutical drug product liability law firm, we have represented thousands of victims of drug-induced injury and death. The firm has been representing victims of harmful drugs for more than 20 years.
Persistent Pulmonary Hypertension of the newborn (PPHN), is a life-threatening disorder in which the newborn’s arteries to the lungs remain constricted after delivery, limiting the amount of blood flow to the lungs and therefore the amount of oxygen into the bloodstream. Ten percent to 20 percent of infants with PPHN will end up dying even if they receive treatment.
A study published in the New England Journal of Medicine (NEJM) in 2006 by Christina Chambers of the University of California, San Diego, found a sixfold increased risk of persistent pulmonary hypertension (PPH) in infants born to mothers who took an antidepressant in the last trimester of pregnancy. On July 19, 2006, the FDA issued a Public Health Advisory for Celexa (citalopram) and several other antidepressants based on this study.
Since September 2005, information has been emerging that certain antidepressants may cause birth defects, including cardiac (heart), pulmonary (lung), craniosynostosis (skull defect) and infant omphalocele (abdominal wall defects). Baum Hedlund is investigating whether or not other antidepressants, such as Celexa, cause these birth defects as well.
If you believe your child's birth defects or PPHN may be related to the use of
Celexa or other antidepressants during pregnancy,
Contact Baum, Hedlund, Aristei & Goldman
today for a free consultation. |
Baum Hedlund has represented victims of antidepressants in personal injury and wrongful death cases for more than 17 years. We have seen the harm antidepressants can cause and the extent to which drug companies will go to protect their enormously profitable drugs. While representing our clients, we dig deep into drug company files to discover the truth about what the company knew about the drug’s risks, when the company knew of those risks and what efforts, if any, the company took to hide those risks. Only through legal action can anyone gain access to much of this information.
For more information about Celexa or to find out more about your legal rights,
please visit www.antidepressantbirthdefects.com and www.pphnlawyers.com.
|
